Boeing August deliveries and improved cash flow support recovery, but regulatory milestones still gate the thesis.

What happened

Boeing delivered 51 jets in August, and its stock moved back above $200, as highlighted by The Motley Fool, which points to a massive $715B backlog and improved adjusted free cash flow from -$331M in Q2 2025 to +$631M in Q2 2026. While these are positive signs of operational improvement, the DeepValue master report maintains a WAIT rating, noting that Boeing's next leg depends on FAA-gated milestones such as certification of the 737 North Line and MAX 7/MAX 10 variants. The report also flags that the stock trades at a full valuation of 30.2x EV/EBITDA and carries $43.5B net debt, leaving little margin of safety. The August delivery data is consistent with the ongoing recovery trajectory but does not yet resolve the key regulatory uncertainties that will determine whether the company can achieve its 47→52 737 rate step and convert backlog into cash. Overall, this news is incrementally positive but not thesis-changing.

Implication

For investors, the August delivery figure and positive free cash flow are encouraging, but they do not justify chasing the stock at current levels given its full valuation and high debt. The key watchpoints over the next 6-12 months are FAA production certification for the 737 North Line, formal certification of the MAX 7 and MAX 10, and sustained 787 output increases. If these milestones are achieved on schedule, the stock could re-rate higher as cash flow accelerates; however, any delays or new charges on legacy programs like 777X or VC-25B could reverse the recent gains. The master report suggests waiting for a better entry around $210 or clear regulatory confirmation before adding exposure. Until then, the prudent stance is to hold existing positions and avoid increasing exposure based solely on this news.

Thesis delta

The new information does not alter the thesis; it provides another data point supporting the recovery narrative, but the core risks remain unchanged. The master report's WAIT stance is reaffirmed, as the stock's move above $200 does not address the upcoming FAA certification decisions or potential defense program charges. Therefore, the thesis delta is minimal.